'A Missed Therapeutic Opportunity? SGLT-2 Inhibitor Use in General Medicine Patients With Heart Failure: A Retrospective Audit of Admissions to a Tertiary Health Service'.
Padeepa PereraRonan O'DonnabhainTimothy FazioDouglas JohnsonPeter LangePublished in: Clinical Medicine Insights. Cardiology (2022)
The results of this study identified significant under prescribing of SGLT2-I's in eligible type 2 diabetic patients with heart failure admitted under general medicine.